Follow the 삼성생명 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Banks sector, 삼성생명 has published 78 reports. Market capitalisation: €50,999.2bn. The latest transaction was reported on 24 April 2026 (Other). Among the most active insiders: 박민재. All data is free.
77
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 삼성생명 Buy (bullish), based on 17 analysts. Average price target: ₩411,559.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,536 of 28,124 companies
59.5
score / 100
Value
70
Quality
49
FCF yld10%
Earn yld4.7%
EV/EBITDA8.9x
ROE5.3%
Gross mgn·
Net mgn8.1%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Samsung Life is a South Korean insurance company that provides various life insurance products and financial services. It is listed on the Korea Exchange, under the symbol XKRX.